Personalized Medicine
Learn how genetic testing can help answer your most important health questions.
What can personalized medicine do for me?
Ask a Question
Breast Cancer
- 5-Fluorouracil (5-FU) Response (DPD Deficiency)
- Hereditary Breast and Ovarian Cancer Risk (BRCA Testing)
- Oncotype DX® for Breast Cancer
- Tamoxifen Response
Blood Disorders
- Clopidogrel (Plavix®) Response (CYP2C19)
- Iron Overload (Hemochromatosis)
- Thrombophilia
- Thrombophilia / High Homocysteine (MTHFR)
- Warfarin Response
Colon Cancer
- 5-Fluorouracil (5-FU) Response (DPD Deficiency)
- Familial Adenomatous Polyposis
- Hereditary Non-Polyposis Colorectal Cancer (HNPCC, Lynch Syndrome)
- HNPCC Tumor Screening (MSI/IHC)
- Irinotecan Response (UGT1A1)
- KRAS for Advanced Colon Cancer
- MYH-Associated Polyposis
Developmental Disorders
- Autism Spectrum Disorders — Chromosome Microarray
- Birth Defects — Chromosome Microarray
- Fragile X Syndrome
- Intellectual Disability / Developmental Delay — Chromosome Microarray
- Rett Syndrome
Digestive Diseases
Heart Diseases
- Clopidogrel Response Testing (CYP2C19)
- Familial Hypercholesterolemia
- Hypertrophic Cardiomyopathy
- Long QT Syndrome
- Statin Drug Response (KIF6)
- Warfarin (Coumadin®) Sensitivity (CYP2C9 and VKORC1)
Infectious Diseases
Infertility
- Cystic Fibrosis for Congenital Absence of the Vas Deferens
- Chromosome Analysis and Fertility
- Fragile X Syndrome Carrier Testing for Premature Ovarian Failure
- Y Chromosome Microdeletions
Lung Diseases
Ovarian Cancer
Prenatal Testing
Recurrent Pregnancy Loss
- 5-Fluorouracil (5-FU) Response (DPD Deficiency)
- Abacavir Response (HLA-B*5701)
- Alpha-1 Antitrypsin Deficiency
- Alpha-Thalassemia Carrier Screening
- Antidepressant Drug Response
- Ashkenazi Jewish Carrier Screening
- BCR-ABL Testing for Imatinib (Gleevec®) Response
- Beta-Thalassemia Carrier Screening
- Carbamazepine Response (HLA-B*1502)
- Celiac Disease
- Chromosome Analysis and Fertility
- Chromosome Microarray Testing for Developmental Abnormalities
- Clopidogrel Response Testing (CYP2C19)
- Crohn Disease
- Cystic Fibrosis Carrier Screening
- Cystic Fibrosis Diagnostic Testing
- Cystic Fibrosis for Congenital Absence of Vas Deferens
- Expanded (Multiplex) Carrier Screening
- Familial Adenomatous Polyposis
- Familial Hypercholesterolemia
- Fragile X Syndrome Carrier Testing for Premature Ovarian Failure
- Fragile X Syndrome Diagnostic Testing
- Hereditary Breast and Ovarian Cancer Risk (BRCA Testing)
- Hereditary Non-Polyposis Colorectal Cancer (HNPCC, Lynch Syndrome)
- HNPCC Tumor Screening (MSI/IHC)
- HIV Tropism Testing (CCR5) for Maraviroc Response
- Hypertrophic Cardiomyopathy
- Imatinib Response (BCR-ABL)
- Irinotecan Response (UGT1A1)
- Iron Overload (Hemochromatosis)
- KRAS for Advanced Colon Cancer
- Long QT Syndrome
- Methotrexate Response (MTHFR)
- MYH-Associated Polyposis
- Oncotype DX® for Breast Cancer
- Pregnancy Complications — MTHFR
- Prenatal Carrier Screening
- Prenatal Diagnostic Tests
- Prenatal Screening
- Primary Ciliary Dyskinesia
- Rett Syndrome
- Sickle Cell Carrier Screening
- Spinal Muscular Atrophy
- Statin Response (KIF6)
- Tamoxifen Response
- Thiopurine Drug Response
- Thrombophilia
- Thrombophilia/High Homocysteine — MTHFR
- Warfarin Response
- Y Chromosome Microdeletions